Recent Funding
Investors
Hatteras Venture Partners

Hatteras Venture Partners portfolio

Hatteras Venture Partners has 4 portfolio companies on record at Recent Funding.

Website: hatterasvp.com.

Type: Venture capital.

Portfolio on Recent Funding: 4.

Deals, last 12 months: 0.

Capital in their rounds: $128M.

Latest deal: Endogenex · Jun 25, 2024.

About this page

It is a venture capital firm based in Research Triangle, US, founded in 1999. Its most recent investment on record is Endogenex's $88M Series B+ round in June 2024, alongside Longitude Capital, Orlando Health Ventures, Intuitive Ventures and 3 others. By category, its portfolio leans toward Health and bio (4) and Manufacturing and industrial (1). It has co-invested with Lumira Ventures, Mayo Clinic and Orlando Health Ventures.

About Hatteras Venture Partners

Firm type: Venture capital.

Headquarters: Research Triangle, US.

Founded: 1999.

Stages: Seed, Series A, Series B, Series C.

Sectors: Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.

Check size: $500K to $4M.

Leads rounds: No.

Portfolio companies: 62.

Exits: 1.

Rounds led: 0.

Fund returns

Fund	Vintage	Size	Net IRR	TVPI	DPI	As of
Hatteras Venture Partners V	2015	—	35.3%	2.08x	1.35x	Sep 30, 2025
Hatteras Venture Partners III, L.P.	2007	—	0.3%	—	—	Jun 30, 2024

Funds raised

Fund	Fund #	Size	Announced
HHatteras Venture Partners Durham, North Carolina	V	$150Mvia Shai Goldman's fund list	Jan 6, 2017

What Hatteras Venture Partners invests in

Health and bio · 4 · 100%
Manufacturing and industrial · 1 · 25%
Media and content · 1 · 25%
Data and analytics · 1 · 25%
Education · 1 · 25%

How Hatteras Venture Partners invests

Stage	Deals	Capital in rounds
Series A	1 50%	$40M
Series B+	1 50%	$88M

Year	Deals	Capital in rounds
2021	1 50%	$40M
2024	1 50%	$88M

Hatteras Venture Partners portfolio companies

EEndogenex$88MSeries B+ · Jun 2024
TTune Therapeutics$40MSeries A · Dec 2021
PPharaoh Neurobacker
CCardiosensebacker

Company	Round with Hatteras Venture Partners	Total raised	Latest raise
EEndogenex Health and bio	Jun 25, 2024 Series B+ · $88M	$138M	Mar 25, 2026 Series B+
TTune Therapeutics Health and bio	Dec 2, 2021 Series A · $40M	$215M	Jan 12, 2025 Series B+
PPharaoh Neuro Health and bio	backer	$20M	Feb 11, 2026 Series A
CCardiosense Health and bio	backer	$15M	Jan 9, 2026 Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Net returns as reported by the public-pension and foundation LPs invested in each fund.

Firm profile and fund returns: Fundraising Fox Open Dataset v2026-09, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Venture funds Hatteras Venture Partners raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.

Share is of the 2 rounds on Recent Funding that name Hatteras Venture Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Hatteras Venture Partners, which is a subset of its real portfolio. API: /api/v1/investors/hatteras-venture-partners (get a free API key). More: the most active VC firms and new venture capital funds.